We are very pleased to announce that Matthias has been awarded an ERC Advanced Grant for his proposal on the NLRP3 inflammasome. The EU will fund the work programme "Exploring inflammasome activation and targeted inhibition" (or "NalpACT" for short) for the next five years. Watch out, what comes out of this endeavour.
